NextGen Omics, Spatial & Data US 2027
Sheraton Boston Hotel, MA
From Novel Technologies to Clinical Applications: Driving the Next Generation of Multi-Omics Research
March 23 – 24, 2027 | Boston, MA
Look Back at NextGen Omics, Spatial & Data US 2026
Together, we can accelerate life changing, targeted, treatments.
NextGen Omics, Spatial & Data US 2026 brought together leading experts in genomics, proteomics, single-cell analysis, spatial imaging, bioinformatics, and diagnostics for an immersive forum on the latest science and technology in multi-omics.
Across two full days, attendees explored everything from technological innovation to therapeutic applications and advanced analysis.
Explore the NextGen Omics, Spatial & Data US Programme
Advancing Therapeutic Innovation Through Multi-Omics Research
NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.
There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology.
Hear from past attendees of last year's Biologics 2024 conference
Explore the NextGen Omics & Spatial Biology US 2025 Programme

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society
Have a peek into the dynamic panels, engaging roundtables, and hands-on workshops happening in Boston - right now!
Spatial Multi-Omics For Target-To-Disease Linkage In Inflammatory Diseases
MARINA BLECK, Principal Scientist, Boehringer Ingelheim
Marina discussed the use of multi omics for faster Faster Target-to- Disease Link (T2DL) with increased confidence and how they can leverage Spatial Biology to enhance the ability to derive insight from human disease tissues. Finally the Importance of FFPE Tissue Quality for Spatial Biology was discussed with the use of QC scoring to determine which FFPE tissue gives the best spatial transcriptomics results.
Spatial Biology As A Discovery Pathway
EMRE ARSLAN, Takeda
Emre Arslan from Takeda gave a talk about the use of Spatial Biology as a discovery pathway. First of all providing an update on the current landscape for spatial technologies then analysing how spatial technologies can be used in clinical trial design - such as the ability to identify previously unknown cell types, interactions and microenvironments and providing an ideal foundation for training better AI models.
JASMINE PLUMMER, Director, St Jude Children's Research Hosptial
Jasmine Plummer's day 2 keynote focused on Single cell into spatial and beyond. "The reason we are in this room is because it’s cutting edge" which is why the single cell and spatial field growing exponentially.
Future directions for the technology include Low throughput, clinical trials, other organisms, more tissue types, epigenomics
JUN WANG, Associate Professor, Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, Stony Brook University
"Simpler but more powerful than flow and imaging cytometry"
MIST Technology provides100 times more information than flow cytometry and currently the highest multiplexity is up to 500 markers/ cell.
Panel Application Of Single Cell Omics In Clinical Monitoring
PRIYA CHOCKALINGAM, Vice President, Head of Clinical BioAnalytics & Translational Sciences, Beam Therapeutics
Priya's talk focused on Genome Editing Technologies for Gene & Cell Therapy and how cell & gene therapies require a specialized regulatory approach compared to other modalities. Appropriate assessments should therefore be put in place in both nonclinical and clinical stages to address safety concerns.
Various methods to assess off-target editing effects have evolved in the last decade. However, limitations remain in balancing accuracy vs sensitivity of these new techniques.
The direct assessment of off-target effects in vivo and in patients is particularly challenging.
Novel single-cell technologies enable quantitation/co-occurrence of on-/off-target editing through patient time-course of treatment
Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling
ZORA MODRUSAN, Senior Director NGS, Genentech
Zora focused on both key insights and future directions of single cell RNA-Seq. scRNA-seq technologies were evaluated and the differences in performance across various metrics such as sensitivity, throughput and cost were compared across different systems.
The Overloading And unpacKing (OAK) method provides a reliable solution for large-scale molecular profiling that incorporates multiple data modalities.
Moving forward they will continue to evaluate the latest scRNA-seq kits to understand differences and guide optimal performance. Zora would also like to enhance OAK's capabilities by integrating additional modalities and applying the platform to a wide range of biological systems.
Key Event Highlights
An unmissable journey awaits you: from celebrated keynote speakers and insightful private roundtables, to the Young Scientist Awards. Discover the moments that will transform your NextGen Omics, Spatial & Data US experience.
Are you developing a cutting-edge therapy, platform or technology? Our Start-Up Zone is designed to support emerging companies looking to increase their visibility, find potential partners or early adopters, and meet their investment goals – connecting them with our community of pharma, investors, and mid-to-large size biotechs.
Located in the Exhibition Hall, the Start-Up Zone allows therapeutic pioneers to showcase their approach, conduct invaluable 1:1 meetings and deliver a quick-fire pitch.
Criteria:
The Start-Up Zone is designed for therapeutic start-ups, academic spin-outs, and early-stage technology/service providers.
To be eligible for inclusion, you must meet the following criteria:
• 0 – 5 years operating
• 0 – 30 employees
• Pre-Series A funding
Successful applicants will receive as part of their package:
• 1 full conference pass
• 10-minute pitch on the Start-Up Stage
• 1x1m space in Start-Up Zone: cocktail table provided, start-up to bring 1x pull-up banner
• Logo featured on website & event platform as a participating start-up
• Ability to arrange 1:1 meetings via to the congress app
Meet Our 2026 Speakers
"NextGen Omics US 2024 was a great networking opportunity, the meeting aspect of appointment setting was great. Everyone has been so helpful and responsive and ahead of our needs."
Regional Oncogenomic Liaison
Exact Sciences
"The support from the Oxford Global team at NextGen Omics US 2024 was excellent - everyone went beyond to help us, it is rare to experience such support."
Chief Business Officer
Scipio Bio
"Very professional and a high dedication to vendor needs and delivering on agreed upon packages. Christian is extremely attentive and customer driven, and this is also demonstrated by the Oxford Global team."
Senior Product Marketing Manager
Levitasbio
"NextGen Omics US was well organised, with highly relevant and engaged attendees."
Senior Sales Specialist, Single-Cell Multiomics
Business Development Manager – Northern Europe, Canopy Biosciences® – A Bruker Company
"NextGen Omics US 2024 was a great, we got good value out of it and are considering coming back to another event!"
Digital Marketing Manager
Allumiqs
Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Meet Our Esteemed Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors
Start-Ups
Sponsors of NextGen Omics, Spatial & Data US 2026 included
Interested in Sponsoring NextGen Omics, Spatial & Data US 2027?

Unlock the Latest News and Insights
Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things Precision Medicine, direct to your inbox.





